Advances in diagnosis and treatment of intestinal Behcet′s disease
10.3760/cma.j.issn.1671-0274.2015.04.028
- VernacularTitle:肠型白塞病的诊断和治疗进展
- Author:
Shengxian FAN
1
;
Yousheng LI
Author Information
1. 210002,南京大学医学院临床学院 南京军区南京总医院 解放军普通外科研究所
- Keywords:
Behcet disease,intestinal;
Clinical features;
Diagnosis;
Treatment
- From:
Chinese Journal of Gastrointestinal Surgery
2015;(4):408-410
- CountryChina
- Language:Chinese
-
Abstract:
Behcet′s disease (BD) affects gastrointestinal tract is defined as intestinal BD. The diagnosis and therapeutic efficacy of intestinal BD are still lack of specific diagnostic method and effective treatment. Intestinal BD is diagnosed according to established criteria based on colonoscopic features and biopsy. To date, 5-aminosalicylic acid and systemic corticosteroids are established as the first-line therapy, while immunosuppressants and infliximab are used as second-line therapy for patients with glucocorticoid resistant. In the process of therapy, we need to carefully evaluate the patient′s condition and be cautious about surgical treatment. Surgical intervention should only be considered in patients with serious complications. In this review, we summarize the recent advances in diagnosis, disease activity index and treatment of intestinal BD, and provide the theoretic proofs to clinical application.
